Matches in Wikidata for { <http://www.wikidata.org/entity/Q64355721> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q64355721 description "im Juni 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64355721 description "wetenschappelijk artikel" @default.
- Q64355721 description "наукова стаття, опублікована в червні 2007" @default.
- Q64355721 name "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 name "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 type Item @default.
- Q64355721 label "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 label "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 prefLabel "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 prefLabel "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 P1433 Q64355721-100FAD67-9C7A-4E7C-9E53-36383FA141DB @default.
- Q64355721 P1476 Q64355721-EF5B5B46-BFB3-4F59-8197-9A85A7002EDE @default.
- Q64355721 P2093 Q64355721-53C5AF5D-B892-44C0-89B4-D1E07F853499 @default.
- Q64355721 P2093 Q64355721-5A152253-8D84-438E-B963-5EB4C302A20C @default.
- Q64355721 P2093 Q64355721-694813AB-D940-4699-B50F-FD9E074A4F7C @default.
- Q64355721 P2093 Q64355721-C5EB8550-0C5E-47CA-ABAA-3393A3964B56 @default.
- Q64355721 P2093 Q64355721-D8866C68-E334-4722-B26E-3C072B3D022C @default.
- Q64355721 P2093 Q64355721-DF5BC94B-8C21-4A7C-8779-CBFAD834F78A @default.
- Q64355721 P2093 Q64355721-EEBB9362-CB6C-4780-949F-7E7D332C8513 @default.
- Q64355721 P2093 Q64355721-FDEA0D34-2E9C-4138-A456-94953D558937 @default.
- Q64355721 P304 Q64355721-F827181D-3BEF-4676-8F8A-511DC79B0EEB @default.
- Q64355721 P31 Q64355721-68B1CE0F-B66A-4474-9DC5-66AA957B4EE2 @default.
- Q64355721 P356 Q64355721-0EE62F2A-56AB-44A4-A6E8-309B804C3835 @default.
- Q64355721 P433 Q64355721-F99603C8-A1EA-4FD0-B431-2F240A05F8A6 @default.
- Q64355721 P478 Q64355721-EF416F25-C004-4E3C-9269-9632525BF724 @default.
- Q64355721 P577 Q64355721-F4131638-A25B-46EB-9832-AAA0C88B271A @default.
- Q64355721 P356 S1567-5688(07)71732-4 @default.
- Q64355721 P1433 Q27714892 @default.
- Q64355721 P1476 "PO22-722 PHARMACOLOGICAL INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN ATTENUATES ATHEROGENIC FEATURES OF POSTPRANDIAL LIPEMIA IN TYPE IIB HYPERLIPIDEMIA" @default.
- Q64355721 P2093 "C. Shear" @default.
- Q64355721 P2093 "E. Duchene" @default.
- Q64355721 P2093 "M. Guerin" @default.
- Q64355721 P2093 "M.J. Chapman" @default.
- Q64355721 P2093 "T. Nguyen" @default.
- Q64355721 P2093 "T. Thuren" @default.
- Q64355721 P2093 "W. Le Goff" @default.
- Q64355721 P2093 "Z. Julia" @default.
- Q64355721 P304 "192-193" @default.
- Q64355721 P31 Q13442814 @default.
- Q64355721 P356 "10.1016/S1567-5688(07)71732-4" @default.
- Q64355721 P433 "1" @default.
- Q64355721 P478 "8" @default.
- Q64355721 P577 "2007-06-01T00:00:00Z" @default.